PRKAA2 and hyperlipidemia: The oral administration of BCS extract (400, 200, and 100 mg/kg), at least under the circumstances of the present study, consistently inhibited the insulin resistance by regulating the AMPK expression, type 2 obese diabetes, and the diabetic complications associated with oxidative stress, such as hyperlipidemia.